• RU
  • KZ
  • RU
  • EN
  • KZ
  • News
  • Cars
  • Opinions
  • Business Guide
  • Stories
  • Kursiv Research
  • Lifestyle
  • SuperJournal
  • Economy
  • Sport
  • Editorial office
  • Advertising
  • Special projects
  • Kazakhstan
  • Uzbekistan
  • Banks & Finance
  • Resources
  • Investments
  • Real Estate
Economy
September 12, 2024

Shares of SpaceX’s small competitor now up over 1,300% since April

Maria Dranishnikova

Maria Dranishnikova

Shares of telecom company AST SpaceMobile, which aims to compete with Elon Musk‘s SpaceX, have skyrocketed over 1,300% since April, when they hit an all-time low. The growth makes AST SpaceMobile the top-performing stock in the small-cap Russell 2000 index over the last six months, Bloomberg reports. The latest gains…

Read more (~3 min.)

Share

  • Link copied
September 11, 2024

Micro-cap Tonix Pharmaceuticals massively undervalued amid monkeypox outbreak — Zacks

Maria Dranishnikova

Maria Dranishnikova

Zacks Small-Cap Research has released a report on Tonix Pharmaceuticals, which is developing a monkeypox vaccine, valuing the stock at $4 per share, nearly 26 times the last closing price. The company’s current market capitalization is around $3.3 million. Details The fair value of a Tonix share is $4, estimates…

Read more (~3 min.)

Share

  • Link copied
September 11, 2024

Russell 2000 set to rally amid Fed rate cuts – Lazard

Maria Dranishnikova

Maria Dranishnikova

Small-cap stocks may be poised for a big rally in the next 6-12 months, according to Sean Gallagher, who oversees investments in the asset class at Lazard. He estimates that the Russell 2000 index could gain as much as 30-50% amid Fed rate cuts. Details Sean Gallagher, the global head…

Read more (~3 min.)

Share

  • Link copied
September 11, 2024

Best-selling drugs in pill form: How Lexaria plans to make it big on weight-loss wave

Maria Dranishnikova

Maria Dranishnikova

Canada’s Lexaria Bioscience, with a market capitalization of just over $50 million on the Nasdaq, is in the business of transforming the delivery of other companies’ drugs. After years of trying to find its niche, the company now intends to make globally best-selling injectable diabetes and obesity drugs from Novo…

Read more (~7 min.)

Share

  • Link copied
September 10, 2024

Terns stock rises on positive early trial of obesity pill

Maria Dranishnikova

Maria Dranishnikova

Shares of Terns Pharmaceuticals, a biotech company with a market capitalization of $641.8 million, surged nearly 17% on Monday, September 9. The trigger was clinical trial results showing that more than half of the patients using the highest dose of the company’s oral weight-loss drug lost 5% of their body…

Read more (~3 min.)

Share

  • Link copied
September 10, 2024

Shares of pre-prepared food maker Mama’s Creations rise after new COO announced

Maria Dranishnikova

Maria Dranishnikova

Quotes on Mama’s Creations, a maker of pre-prepared foods with a market capitalization of $298.1 million, rose 4.6% on Monday, September 9. Earlier in the day, the company announced that Skip Tappan, a manager with experience at Walmart, Procter & Gamble, and Campbell Soup, would be taking over as COO.…

Read more (~2 min.)

Share

  • Link copied
September 9, 2024

Zacks spotlights three stocks poised to benefit from booming tech services market

Maria Dranishnikova

Maria Dranishnikova

The global shift toward digitalization is creating opportunities across various markets as companies integrate AI, machine learning, and blockchain technologies. Zacks has fingered three stocks that could benefit from the rapid growth in what it calls the technology services market: the small caps Byrna Technologies and Climb Global Solutions, as…

Read more (~3 min.)

Share

  • Link copied
September 9, 2024

Satellite communication systems maker SatixFy halves net loss in first half

Maria Dranishnikova

Maria Dranishnikova

SatixFy, an Israeli company with a market capitalization of $60.4 million that develops satellite communication systems, has reported that its net loss more than halved year over year in the first half of 2024. Revenue rose 7% as the company shifted from development and preproduction to product sales. Quotes on…

Read more (~3 min.)

Share

  • Link copied
September 6, 2024

Citius Oncology stock jumps after its drug included in clinical guidelines

Maria Dranishnikova

Maria Dranishnikova

On Thursday, September 5, quotes on late-stage pharmaceutical company Citius Oncology added more than 8%. The company announced that its only approved drug so far, LYMPHIR, made to treat lymphoma, had been added to clinical practice guidelines in oncology, which makes it easier for doctors to prescribe and for insurers…

Read more (~2 min.)

Share

  • Link copied
September 6, 2024

Amazon for patriots: How PSQ Holdings is monetizing Trump campaign slogans

Maria Dranishnikova

Maria Dranishnikova

The U.S. company PSQ Holdings, also known as PublicSquare, brands itself as a marketplace for family-oriented, patriotic and politically conservative Americans. Three years ago, it was just an idea, a few lines of code, and seven employees. “We will become the new Amazon,” proclaims its founder, Michael Seifert. While the…

Read more (~7 min.)

Share

  • Link copied
September 5, 2024

Display manufacturer Daktronics retreats after first-quarter financials

Maria Dranishnikova

Maria Dranishnikova

On Wednesday, September 4, display manufacturer Daktronics saw its stock drop more than 9% after releasing previous-quarter financials. Sales fell 2.8% year over year, while earnings per share missed analysts’ expectations. Details On Wednesday, Daktronics stock lost 9.11% to $12.37 per share, the decline continuing in pre-market trading on Thursday.…

Read more (~2 min.)

Share

  • Link copied
September 5, 2024

Athira stock plummets after its Alzheimer’s treatment fails in trials

Maria Dranishnikova

Maria Dranishnikova

On Wednesday, September 4, quotes on Athira Pharma, a small developer of therapies for neuronal health, plummeted 78% after the company reported that its Alzheimer’s treatment had not been found significantly more effective than placebo in a 26-week clinical trial. Despite this setback, Athira intends to continue working on the…

Read more (~4 min.)

Share

  • Link copied
September 4, 2024

Eyewear retailer KITS upgrades revenue guidance after strong August

Maria Dranishnikova

Maria Dranishnikova

Canada’s KITS Eyecare, a retailer of eyewear and contact lenses, has upgraded its revenue guidance for the third quarter of 2024 just a month after announcing the previous estimate. Analysts have taken note and raised their target prices for the stock. Details KITS Eyecare has announced that it sees upside…

Read more (~3 min.)

Share

  • Link copied
September 4, 2024

Less-lethal weapons maker Byrna preliminarily reports 200% revenue growth, stock soars

Maria Dranishnikova

Maria Dranishnikova

Shares of less-lethal weapons manufacturer Byrna Technologies have surged more than 20% today, Wednesday, September 4. The trigger was preliminary third-quarter earnings, with revenue nearly tripling. Details  At the start of trading on Wednesday, Byrna Technologies stock jumped 20.4% to $12.94 per share, the highest mark since May. For the…

Read more (~2 min.)

Share

  • Link copied
September 4, 2024

Haypp could lose 20% of sales in Stockholm city crackdown on snus

Maria Dranishnikova

Maria Dranishnikova

The city of Stockholm has proposed revoking the Swedish sales permit for traditional snus from a Haypp Group subsidiary, the company reported. Snus in Sweden accounts for a fifth of total sales. Today, Wednesday, September 4, Haypp shares opened lower on the Nasdaq First North Growth Market for smaller European…

Read more (~3 min.)

Share

  • Link copied
September 3, 2024

Barchart.com contributor fingers small AI company with 79% upside

Maria Dranishnikova

Maria Dranishnikova

The stock of fintech company Pagaya Technologies is trading with 79% upside versus its last closing price, notes Barchart.com contributor Ruchi Gupta, citing analysts’ consensus forecasts. Pagaya has developed an AI platform that helps banks, retailers, and payment systems to make lending  decisions. Details The average target price for Pagaya…

Read more (~3 min.)

Share

  • Link copied
September 3, 2024

Insider Monkey names seven AI penny stocks most popular with hedge funds

Maria Dranishnikova

Maria Dranishnikova

The consulting firm Grand View Research expects the global AI market to grow from less than $200 billion in 2023 to $1.8 trillion by 2030. Against this backdrop, the tech giants driving AI adoption are Wall Street favorites, making it increasingly difficult to find stocks with untapped potential. Insider Monkey…

Read more (~4 min.)

Share

  • Link copied
September 2, 2024

Zacks spotlights cancer and sepsis test developer VolitionRx as undervalued

Maria Dranishnikova

Maria Dranishnikova

Zacks Small-Cap Research (Zacks SCR) published a report last week on VolitionRx, which develops and sells early-detection tests for serious diseases. It set a target price for the stock of $3.60 per share, five times the closing price as of Friday, August 30, noting the company’s expanding distribution network and…

Read more (~3 min.)

Share

  • Link copied
August 30, 2024

Value of company developing kidney disease treatments doubles in one day

Maria Dranishnikova

Maria Dranishnikova

Shares of XORTX Therapeutics, which is focused on developing drug therapies to treat progressive kidney disease, soared about 136% on Thursday, August 29. The company highlighted research that established a link between genetic factors and several diseases, including kidney disease. This might expand the market for XORTX therapies, as the…

Read more (~3 min.)

Share

  • Link copied
August 29, 2024

Small caps and the U.S. election: How investors can win in the home stretch

Maria Dranishnikova

Maria Dranishnikova

The unexpected entry of Kamala Harris into the presidential race on July 21 drove a 5.7% rise in the shares of AdvisorShares Pure US Cannabis ETF, which provides investors with access to U.S. cannabis companies, with a 19% increase in the number of shares changing hands. More than half of…

Read more (~8 min.)

Share

  • Link copied
August 29, 2024

Byrna shares rise after Uruguay buys its less-lethal launchers, ammunition

Maria Dranishnikova

Maria Dranishnikova

Shares of less-lethal weapons manufacturer Byrna Technologies rose 2.6% on Wednesday, August 28. The company announced that the Uruguayan government had purchased launchers and ammunition for use by the National Police. Details  Byrna stock gained 2.56% to $11.22 per share on the Nasdaq on Wednesday, having risen as high as…

Read more (~2 min.)

Share

  • Link copied
August 28, 2024

Pharmaceutical company Sonoma slides after reverse stock split announced

Maria Dranishnikova

Maria Dranishnikova

Sonoma Pharmaceuticals, which develops treatments for dermatological conditions and advanced wound care with its flagship product stabilized hypochlorous acid, slid almost 14% in pre-market trading today, Wednesday, August 28. This follows an announced reverse stock split to maintain the company’s listing. Details In trading before the open on Wednesday, Sonoma…

Read more (~3 min.)

Share

  • Link copied
August 28, 2024

La Rosa Holdings shares advance after acquisition of competitor

Maria Dranishnikova

Maria Dranishnikova

Shares of La Rosa Holdings, which provides real estate brokerage and related services, advanced about 5% on Tuesday, August 27. The trigger was an announcement that the company had completed the acquisition of a competitor, which will enable it to offer new services, including title insurance. Details  La Rosa Holdings…

Read more (~2 min.)

Share

  • Link copied
August 27, 2024

Vaping addiction treatment developer changes CEO, possibly ahead of sale

Maria Dranishnikova

Maria Dranishnikova

Achieve Life Sciences, a pharmaceutical company developing the first vaping addiction treatment, has announced a new CEO. It explained that it needs a leader with substantial experience in M&A and drug commercialization. Freedom Finance Global Senior Analyst Ilya Zubkov believes that this move could indicate a potential sale of Achieve.…

Read more (~3 min.)

Share

  • Link copied
Latest news
June 26, 2025

From microfinance to major moves: BNK sets its banking agenda in Kazakhstan

kazatomprom.kz, бильд-редактор: Милош Муратовский
June 25, 2025

US security probe into foreign uranium sparks response from top producer Kazatomprom

June 25, 2025

South Korean financiers obtain banking license in Kazakhstan

tengizchevroil.com, бильд-редактор: Милош Муратовский
June 24, 2025

Tengiz oil production forecast gets a boost

June 23, 2025

Pros and cons: Differing views emerge on the AIFC’s future in Kazakhstan

Новости партнеров
Show more
1 … 11 12 13 14 15 … 38
© 2004-2025. All rights reserved.

The site is registered with the Information Committee, Ministry of Information and Communications of the Republic of Kazakhstan

The information products of this web publishing are intended for persons aged 18 and over

To top
  • About us
  • Confidentiality Policy of Alteco Partners
  • Archive
  • Rules for the processing of personal data
  • Contacts
  • Rules for the use of information